Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OMB Director Defends Cost Reduction Elements Of Health Reform Law

This article was originally published in The Gray Sheet

Executive Summary

White House Office of Management and Budget Director Peter Orszag is defending the Patient Protection and Affordable Care Act's ability to bring down the long-term growth in U.S. health care costs

You may also be interested in...



Senators Plan Effort To Repeal Independent Payment Advisory Board

Sen. Orrin Hatch, R-Utah, plans to reintroduce legislation to repeal the Independent Payment Advisory Board, established by the health care reform law to take some of the congressional politics out of efforts to curb Medicare spending growth.

Senators Plan Effort To Repeal Independent Payment Advisory Board

Sen. Orrin Hatch, R-Utah, plans to reintroduce legislation to repeal the Independent Payment Advisory Board, established by the health care reform law to take some of the congressional politics out of efforts to curb Medicare spending growth.

CMS Nominee Berwick Poised To Implement Health Reform, If Confirmed

Health care policy insiders are expressing enthusiasm over the nomination of Harvard professor Donald Berwick to lead CMS, and hope for a quick Senate confirmation so the Medicare agency can get down to the heavy lifting of implementing health care reform

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029032

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel